Back to mobile site

Corbus Pharma (CRBP) Misses Q4 EPS by 125c

March 9, 2026 7:41 AM EDT

Corbus Pharma (NASDAQ: CRBP) reported Q4 EPS of ($1.25).

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK